Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02807779 · ClinicalTrials.gov registry record · Phase 4
Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
NCT02807779 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 33 participants.
The verdict
NCT02807779, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, randomized trial to determine the mechanisms of vascular healing. The study will evaluate subjects with peripheral artery disease (PAD) who require an endovascular intervention of the femoro-popliteal (SFA) artery to restore blood flow to the leg.
Interventions
- DRUG Dexamethasone infusion
- DEVICE Drug coated balloon
- DEVICE Plain balloon angioplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-02-10 |
| Est. Completion | 2022-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02807779
The ClinicalTrials.gov registry entry for NCT02807779 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dexamethasone infusion is the first listed.
NCT02807779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02807779 about?
NCT02807779 is a clinical study titled "Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging". This is a prospective, multicenter, randomized trial to determine the mechanisms of vascular healing. The study will evaluate subjects with peripheral artery disease (PAD) who require an endovascular intervention of the femoro-popliteal (SFA) artery to restore blood flow to the leg.
What is the current status of trial NCT02807779?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2016-02-10. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT02807779?
The interventions under investigation include: Dexamethasone infusion (DRUG), Drug coated balloon (DEVICE), Plain balloon angioplasty (DEVICE).
Who is sponsoring clinical trial NCT02807779?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.